MAM
AMED

Martingale Asset Management’s Amedisys AMED Stock Holding History

Martingale Asset Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-901
Closed -$214K – 873
2020
Q3 		$214K Sell
901
-200
-18% -$45.5K ﹤0.01% 963
2020
Q2 		$219K Sell
1,101
-1
-0.1% -$187 ﹤0.01% 978
2020
Q1 		$203K Sell
1,102
-400
-27% -$71.2K ﹤0.01% 924
2019
Q4 		$251K Buy
+1,502
New +$223K ﹤0.01% 933
2019
Q2 		– Sell
-21,606
Closed -$2.66M – 1005
2019
Q1 		$2.66M Sell
21,606
-1,400
-6% -$176K 0.03% 524
2018
Q4 		$2.69M Buy
23,006
+2,500
+12% +$295K 0.04% 474
2018
Q3 		$2.56M Buy
+20,506
New +$2.26M 0.03% 486

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Martingale Asset Management's AMED Position: Q4 2020 in Review

Martingale Asset Management sold out of Amedisys (AMED) in Q4 2020, closing a stake of 901 shares — an estimated $214K sold.

Martingale Asset Management first reported a position in AMED in Q3 2018 and held it in 7 quarters. The position peaked at $2.69M in Q4 2018. 396 funds tracked by Wall St. Rank hold AMED as of Q4 2020.

  • Martingale Asset Management reported no remaining Amedisys position as of Q4 2020 after selling out during the quarter.
  • Martingale Asset Management sold 901 Amedisys shares in Q4 2020, an estimated $214K.
  • Martingale Asset Management first reported a position in Amedisys in Q3 2018 and held it in 7 quarters.
  • Martingale Asset Management's Amedisys position peaked at $2.69M in Q4 2018.
  • 396 funds tracked by Wall St. Rank held Amedisys as of Q4 2020.

Based on Martingale Asset Management's 13F filing for Q4 2020, filed 10 Feb 2021.